Burning Rock Biotech (BNR) Accounts Payables (2019 - 2025)

Burning Rock Biotech's Accounts Payables history runs 7 years deep, the most recent figure standing at $5.7 million for Q4 2025.

• In Q4 2025, Accounts Payables rose 22.27% year-over-year to $5.7 million; the TTM figure through Dec 2025 stood at $5.7 million (up 22.27% YoY), while the FY2025 annual figure was $5.8 million, up 26.02% from the prior year.
• Accounts Payables was $5.7 million for Q4 2025 at Burning Rock Biotech, up from $4.8 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $15.4 million in Q1 2022 to a low of $2.5 million in Q4 2023.
• Historically, Accounts Payables has averaged $6.1 million across 5 years, with a median of $4.9 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Accounts Payables surged 102.92% in 2022, then tumbled 77.76% in 2023.
• A 5-year view of Accounts Payables shows it stood at $9.9 million in 2021, then declined by 27.4% to $7.2 million in 2022, then plunged by 64.98% to $2.5 million in 2023, then jumped by 87.29% to $4.7 million in 2024, then advanced by 22.27% to $5.7 million in 2025.
• The last three Accounts Payables figures came in at $5.7 million (Q4 2025), $4.8 million (Q3 2025), and $4.5 million (Q2 2025), per Business Quant data.